DEA Places Post-Partum Depression Treatment Into Schedule IV

The Drug Enforcement Administration is placing the newly approved drug zuranolone in Schedule IV of the Controlled Substances Act, it said in an interim final rule. Effective Oct. 31, zuranolone, which was granted FDA approval in May, is subject to new registration, labeling, record-keeping, and import and export requirements. DEA is accepting comments on the rule until Nov. 30.